Fact Based List:
The 10 drugs for which companies spent the most in payments to physicians in 2015
Submitted by Anonymous on Wed, 12/14/2016 - 18:47
- Xarelto ($28.4 Million)
- Humira ($24.9 Million)
- Invokana ($20.9 Million)
- Viekira ($19.2 Million)
- Eliquis ($18.8 Million)
- Bydureon ($18.5 Million)
- Androgel ($15.3 Million)
- Synthroid ($14.7 Million)
- Lupron ($14.3 Million)
- Victoza ($11.9 Million)
Source: Pro Publica
Source URL: https://www.propublica.org/article/updated-dollars-for-docs-...
Printer-friendly version
Send to friend| List Ratings: |
Lists You Might Also Be Interested In
- AAMC Report: 6 Key Findings About Projected Shortage of Physicians by 2032
- Geographic Distribution of Primary Care Family Physicians
- WalletHub: The Ten Best States for Physicians to Pracice In
- Physician Specialists’ Usage of Digital Technology in Medical Practice
- Medscape: Percentage of Physicians Participating in Various Payment Models
Login or register to post comments
